MetaCap

Century Therapeutics Statistics

NASDAQ: IPSCHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD

1.17-0.155 (-11.74%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Century Therapeutics by the numbers

Century Therapeutics has a market capitalization of $211.6 million based on 181.60M shares outstanding. With trailing EPS of $-0.64, Century Therapeutics is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 26.3% below its 50-day average and 43.3% below its 200-day average.

Average daily trading volume is 759.69K shares, or about $885,042 in dollar volume.

Summary generated from market data by MetaCap's automated system. Methodology

IPSC valuation vs. peer median

IPSC compared with the median of 8 peer companies
MetricIPSCPeer medianDifference
Market cap$211.56M$209.71M+1%
Avg. volume759.69K1.27M-40%

Peer median across 8 companies: ALLO, CABA, LCTX, SCTX, ARTV, IKT, AUTL, PLX.

Valuation

Market cap
$211.56M
Price / sales (latest FY)
1.94
EPS (TTM)
$-0.64

Price and trading

Previous close
1.32
Open
1.32
Day range
1.16 – 1.32
52-week range
0.48 – 3.04
52-week change
+137.76%
Beta
—
Volume
916.11K

Dividends and events

Annual dividend
None
Next earnings date
Nov 12, 2026

Additional statistics

Market Cap
211.56M
Forward Pe
-2.68
Eps
-0.64
Dividend Yield
0.00%
Dividend Rate
0.00
Week52 High
3.04
Week52 Low
0.48
Avg Volume
759.69K
Shares Outstanding
181.60M
Ma50
1.58
Ma200
2.05
Earnings Date
Nov 12, 2026
Pct From52w High
-61.68%
Pct From52w Low
142.71%

Related